Comparison of Serum Levels of Inflammatory Markers in Patients With Coronary Vasospasm Without Significant Fixed Coronary Artery Disease Versus Patients With Stable Angina Pectoris and Acute Coronary Syndromes With Significant Fixed Coronary Artery Disease

American Journal of Cardiology

Volumn 97, Issue 10, 2006, Pages 1429-1434

  Hung, Ming Jui ^a,b   Cherng, Wen Jin ^a   Cheng, Chi Wen ^a   Li, Li Fu ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NICORANDIL; NITRATE; VASCULAR ADHESION PROTEIN 1;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE;

AGED; AMINE OXIDASE (COPPER-CONTAINING); ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CHEMOKINE CCL2; CORONARY ARTERIOSCLEROSIS; CORONARY VASOSPASM; FEMALE; HEART CATHETERIZATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 33646202185     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.12.035     Document Type: Article

References (24)

1. Hung M.J., and Cherng W.J. Comparison of white blood cell counts in acute myocardial infarction patients with significant versus insignificant coronary artery disease. Am J Cardiol 91 (2003) 1339-1342
2. Hung M.J., Kuo L.T., Cheng C.W., Chang C.P., and Cherng W.J. Comparison of peripheral monocyte counts in patients with and without coronary spasm and without fixed coronary narrowing. Am J Cardiol 93 (2004) 620-624
3. Beltrame J.F., Sasayama S., and Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity. differences between Japanese and Caucasian patients. J Am Coll Cardiol 33 (1999) 1442-1452
4. Hung M.J., Cherng W.J., Cheng C.W., and Yang N.I. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. Am J Cardiol 95 (2005) 84-87
5. Yamagishi M., Miyatake K., Tamai J., Nakatani S., Koyama J., and Nissen S.E. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 23 (1994) 352-357
6. Miyao Y., Kugiyama K., Kawano H., Motoyama T., Ogawa H., Yoshimura M., Sakamoto T., and Yasue H. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 36 (2000) 432-437
7. Roberts W.C., Curry Jr. R.C., Isner J.M., Waller B.F., McManus B.M., Mariani-Constantini R., and Ross A.M. Sudden death in Prinzmetal's angina with coronary spasm documented by angiography. Analysis of three necropsy patients. Am J Cardiol 50 (1982) 203-210
8. Suzuki H., Kawai S., Aizawa T., Kato K., Sunayama S., Okada R., and Yamaguchi H. Histological evaluation of coronary plaque in patients with variant angina. relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. J Am Coll Cardiol 33 (1999) 198-205
9. Marzilli M., Goldstein S., Trivella M.G., Palumbo C., and Maseri A. Some clinical considerations regarding the relation of coronary vasospasm to coronary atherosclerosis. a hypothetical pathogenesis. Am J Cardiol 45 (1980) 882-886
10. Nobuyoshi M., Tanaka M., Nosaka H., Kimura T., Yokoi H., Hamasaki N., Kim K., Shindo T., and Kimura K. Progression of coronary atherosclerosis. is coronary spasm related to progression?. J Am Coll Cardiol 18 (1991) 904-910
11. Ozaki Y., Keane D., and Serruys P.W. Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina. Circulation 92 (1995) 2446-2456
12. Widlansky M.E., Gokce N., Keaney Jr. J.F., and Vita J.A. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42 (2003) 1149-1160
13. Zeiher A.M., Drexler H., Wollschläger H., and Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83 (1991) 391-401
14. Miwa K., Igawa A., and Inoue H. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 36 (1997) 37-44
15. Kugiyama K., Ota Y., Kawano H., Soejima H., Ogawa H., Sugiyama S., Doi H., and Yasue H. Increase in plasma levels of secretory type II phospholipase A2 in patients with coronary spastic angina. Cardiovasc Res 47 (2000) 159-165
16. Hung M.J., Cherng W.J., Yang N.I., Cheng C.W., and Li L.F. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 96 (2005) 1484-1490
17. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem J 265 (1990) 621-636
18. Mestries J.C., Kruithof E.K., Gascon M.P., Herodin F., Agay D., and Ythier A. In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons. Eur Cytokine Netw 5 (1994) 275-281
19. Vigushin D.M., Pepys M.B., and Hawkins P.N. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 91 (1993) 1351-1357
20. Papanicolaou D.A., Wilder R.L., Manolagas S.C., and Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128 (1998) 127-137
21. Soejima H., Irie A., Miyamoto S., Kajiwara I., Kojima S., Hokamaki J., Sakamoto T., Tanaka T., Yoshimura M., Nishimura Y., and Ogawa H. Preference toward a T-helper type 1 response in patients with coronary spastic angina. Circulation 107 (2003) 2196-2200
22. Soejima H., Miyamoto S., Kojima S., Hokamaki J., Tanaka T., Kawano H., Sugiyama S., Sakamoto T., Yoshimura M., Kishikawa H., and Ogawa H. Coronary spastic angina in patients with connective tissue disease. Circ J 68 (2004) 367-370
23. de Feyter P.J., Ozaki Y., Baptista J., Escaned J., Di Mario C., de Jaegere P.P., Serruys P.W., and Roelandt J.R. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation 92 (1995) 1408-1413
24. Maehara A., Mintz G.S., Bui A.B., Walter O.R., Castagna M.T., Canos D., Pichard A.D., Satler L.F., Waksman R., Suddath W.O., et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 40 (2002) 904-910